Annexin V is directly involved in cystic fibrosis transmembrane conductance regulator's chloride channel function

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 10, 2007, Pages 1121-1133

  Trouvé, Pascal ^a   Le Drévo, Marie Anne ^a   Kerbiriou, Mathieu ^a   Friocourt, Gaëlle ^a   Fichou, Yann ^a   Gillet, Danièle ^a   Férec, Claude ^a  

^a INSERM   (France)

Author keywords

Normal CFTR function; Protein localization; Protein protein interaction

Indexed keywords

ACTIN; CHLORIDE CHANNEL; LIPOCORTIN 5; NUCLEOTIDE BINDING PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CELL MEMBRANE; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

ADENOSINE TRIPHOSPHATE; ANNEXIN A5; CALCIUM; CELL LINE; CELL MEMBRANE; CYCLIC AMP; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SURFACE PLASMON RESONANCE; TRACHEA;

EID: 36549005585     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.06.006     Document Type: Article

References (49)

1. Riordan J.R., Rommens J.M., Kerem B.S., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.L., Drumm M.L., Iannuzzi M.C., Collins F.S., and Tsui L.C. Identification of cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989) 1066-1073
2. Welsh M.J., Tsui L.C., Boat T.F., and Beaudet A.L. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease. 7th edition (1995), McGraw-Hill, New York 3799-3876
3. Drumm M.L., Pope H.A., Cliff W.H., Rommens J.M., Marvin S.A., Tsui L., Collins F.S., Frizzel R.A., and Wilson J.M. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 62 (1990) 1227-1233
4. Rich D.P., Anderson M.P., Gregory R.J., Cheng S.H., Paul S., Jefferson D.M., McCann J.D., Klinger K.W., Smith A.E., and Welsh M.J. Expression of the cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 347 (1990) 358-363
5. Szellas T., and Nagel G. Apparent affinity of CFTR for ATP is increased by continuos kinase activity. FEBS Lett. 535 (2003) 141-146
6. Cheng S.H., Rich D.P., Marshall J., Gregory R.J., Welsh M.J., and Smith A.E. Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell 66 (1991) 1027-1036
7. Anderson M.P., and Welsh M.J. Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. Science 257 (1992) 1701-1704
8. Quinton P.M., and Reddy M.M. Control of CFTR chloride conductance by ATP levels through non-hydrolytic binding. Nature 360 (1992) 79-81
9. Howell L.D., Borchardt R., Kole J., Kaz A.M., Randak C., and Cohn J.A. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR domain. J. Biochem. 378 (2004) 151-159
10. Ramjeesingh M., Ugwu F., Li C., Dhani S., Huan L.J., Wang Y., and Bear C.E. Stable dimeric assembly of the second membrane-spanning domain of CFTR reconstitutes a chloride-selective pore. Biochem. J. 375 (2003) 633-641
11. Naren A.P., Cormet-Boyaka E., Fu J., Villain M., Blalock J.E., Quick M.W., and Kirk K.L. CFTR chloride channel regulation by an interdomain interaction. Science 286 (1999) 544-548
12. Naren A.P., and Kirk K.L. CFTR chloride channels: binding partners and regulatory networks. News Physiol. Sci. 15 (2000) 57-61
13. Naren A.P., Nelson D.J., Xie W., Jovov B., Pevsner J., Bennett M.K., Benos D.J., Quick M.W., and Kirk K.L. Regulation of CFTR chloride channels by syntaxin and Munc 18 isoforms. Nature 390 (1997) 302-305
14. Naren A.P., Quick M.W., Collawn J.F., Nelson D.J., and Kirk K.L. Syntaxin 1A inhibits CFTR chloride channels by means of domain-specific protein-protein interactions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10972-10977
15. Sun F., Hug M.J., Lewarchik C.M., Yun C.H.C., Bradbury N.A., and Frizzell R.A. E3KARP mediates the association of ezrin and protein kinase A with the cystic fibrosis transmembrane conductance regulator in airway cells. J. Biol. Chem. 275 (2000) 29539-29546
16. Della Gaspera B., Weinman S., Huber C., Lemnaouar M., Paul A., Picard J., and Gruenert D.C. Overexpression of Annexin V in CF epithelial cells from fetal trachea. Exp. Cell Res. 219 (1995) 379-383
17. Meers P., and Mealy T. Calcium-dependent annexin V binding to phospholipids: stoichiometry, specificity, and the role of negative charge. Biochemistry 32 (1993) 11711-11721
18. Mira J.P., Dubois T., Oudinet J.P., Lukowski S., Russo-Marie F., and Geny B. Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition. J. Biol. Chem. 272 (1997) 10474-10482
19. Montaville P., Neumann J.M., Russo-Marie F., Oschenbein F., and Sanson A. A new consensus sequence for phosphatidylserine recognition by annexins. J. Biol. Chem. 277 (2002) 24684-24693
20. Eidelman O., Barnoy S., Razin M., Zhang J., McPhie P., Lee G., Huang Z., Sorscher E.J., and Pollard H.B. Role for phospholipid interactions in the trafficking defect of Delta F508-CFTR. Biochemistry 37 (2002) 11161-11170
21. Camors E., Charue D., Trouvé P., Monceau V., Loyer X., Russo-Marie F., and Charlemagne D. Association of annexin A5 with Na(+)/Ca(2+) exchanger and caveolin3 in non-failing and failing human heart. J. Mol. Cell. Cardiol. 40 (2005) 47-55
22. Lowry O.H., Rosebrough H.J., Farr A.L., and Randall R.J. Protein measurement with the Pholin phenol reagent. J. Biol. Chem. 183 (1951) 263-275
23. Annereau J.P., Wulbrand U., Vankeerberghen A., Cuppens H., Bontems F., Tummler B., Cassiman J.J., and Stoven V. A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator. FEBS Lett. 407 (1997) 303-308
24. Ramjeesingh M., Huan L.J., Garami E., and Bear C.E. Novel method for evaluation of the oligomeric structure of membrane proteins. Biochem. J. 342 (1999) 119-123
25. Skach W.R. In cystic fibrosis methods and protocols. Methods in Molecular Medicine (2002), Humana Press
26. Ramjeesingh M., Li C., Garami E., Huan L.J., Hewryk M., Wang Y., Galley K., and Bear C.E. A novel procedure for the efficient purification of the CFTR. Biochem. J. 327 (1997) 17-21
27. Verzili D., Zamparelli C., Mattei B., Noegel A.A., and Chiancone E. The sorcin-annexin VII calcium-dependent interactions requires the sorcin N-terminal domain. FEBS Lett. 471 (2000) 197-200
28. Nieba L., Nieba-Axmann S.E., Persson A., Hamalaien M., Edebratt F., Hansson A., Lidholm J., Magnusson K., Karlsson A.F., and Pluckthum A. BIACORE analysis of histidine-tagged proteins using a chelating NTA sensor chip. Ann. Biochem. 252 (1997) 217-228
29. Leblais V., Demolombe S., Vallette G., Langin D., Baro I., Escande D., and Gauthier C. β3-adrenoreceptor control the CFTR conductance through a cAMP/PKA-independent pathway. J. Biol. Chem. 274 (1999) 6107-6113
30. Chappe V., Hinkson D.A., Chang X.B., Riordan J.R., and Hanrahan J.W. Phosphorylation of protein kinase C sites in NBD1 and the R domain control CFTR channel activation by PKA. J. Physiol. 548 (2003) 39-52
31. Konishi Y., Sato H., and Tanaka T. Anisomycin superinduces annexin V mRNA expression through the ERK1/2 but not the p38 MAP kinase pathway. Biochem. Biophys. Res. Commun. 313 (2004) 977-983
32. Dubois T., Mira J.P., Feliers D., Solito E., Russo-Marie F., and Oudinet J.P. Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration. Biochem. J. 330 (1998) 1277-1282
33. Gerke V., and Moss S.E. Annexins: from structure to function. Physiol. Rev. 82 (2002) 331-371
34. Doucet L., Mendes F., Montier T., Delépine P., Penque D., Férec C., and Amaral M.D. Applicability of different antibodies for the immunohistochemical localization of CFTR in respiratory and intestinal tissues of human and murine origin. J. Histochem. Cytochem. 51 (2003) 1191-1199
35. Bensalem N., Ventura A.P., Vallee B., Lipecka J., Tondelier D., Davezac N., Dos Santos A., Perretti M., Fajac A., Sermet-Gaudelus I., Renouil M., Lesure J.F., Halgand F., Laprevote O., and Edelman A. Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients. Mol. Cell Proteomics. 4 (2005) 1591-1601
36. Fagerstam L.G., Frostell-Karlsson A., Karlsson R., Persson B., and Ronnberg I. Biospecific interaction analysis using SPR detection applied to kinetic, binding site and concentration analysis. J. Chromatogr. 597 (1992) 397-410
37. Raynal P., and Pollard H.B. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim. Biophys. Acta 1197 (1994) 63-93
38. Capila I., VanderNoot V.A., Mealy T.R., Seaton B.A., and Robert R.J. Interaction of heparin with annexin V. FEBS Lett. 446 (1999) 327-330
39. Bargon J., Trapnell B.C., Chu C.S., Rosenthal E.R., Yoshimura K., Guggino W.B., Dalemans W., Pavirani A., Lecocq J.P., and Crystal R.G. Down-regulation of cystic fibrosis transmembrane conductance regulator gene expression by agents that modulate intracellular divalent cations. Mol. Cell. Biol. 12 (1992) 1872-1878
40. Prat A.G., Cunningham C.C., Jackson G.R., Borkan S.C., Wang Y., Ausiello D.A., and Cantiello H.F. Actin filament organization is required for proper cAMP-dependent activation of CFTR. Am. J. Physiol. 277 (1999) C1160-C1169
41. Kheifets V., Bright R., Inagaki K., Schechtman D., and Mochly-Rosen D. Protein kinase C delta (deltaPKC)-annexin V interaction: a required step in deltaPKC translocation and function. J. Biol. Chem. 281 (2006) 23218-23226
42. Berendes R., Voges D., Demange P., Huber R., and Burger A. Structure-function analysis of the ion channel selectivity filter in human annexin V. Science 262 (1993) 427-430
43. Tzima E., Trotter P.J., Orchard M.A., and Walker J.H. Annexin V relocates to the platelet cytoskeleton upon activation and binds to a specific isoform of actin. Eur. J. Biochem. 267 (2000) 4720-4730
44. i signals in human cystic fibrosis airway epithelia. J. Biol. Chem. 280 (2005) 10202-10209
45. Vazquez E., Nobles M., and Valverde M.A. Defective regulatory volume decrease in human cystic fibrosis tracheal cells because of altered regulation of intermediate conductance Ca2+-dependent potassium channels. Proc. Natl. Acad. Sci. 98 (2001) 5329-5334
46. Wang S., Yue H., Derin R.B., Guggino W.B., and Li M. Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity. Cell 103 (2000) 169-179
47. Guggino W.B., and Stanton B.A. New insights into cystic fibrosis: molecular switches that regulate CFTR. Nat. Rev., Mol. Cell Biol. 7 (2006) 426-436
48. Pollard H.B., Ji X.D., Jozwik C., and Jacobowitz D.M. High abundance protein profiling of cystic fibrosis lung epithelial cell. Proteomics 5 (2005) 2210-2226
49. Sohma H., Ohkawa H., Akino T., and Kuroki Y. Binding of annexins to lung lamellar bodies and the PMA-stimulated secretion of Annexin V from alveolar type II cells. J. Biochem. 130 (2001) 449-455